Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting
Stephanie H. Wilson, MBBS, FRACP*,
Panayotis Fasseas, MD ,
James L. Orford, MBChB, MPH ,
Ryan J. Lennon, MS ,
Terese Horlocker, MD||,
Nina E. Charnoff, MD||,
Steven Melby, RN¶ and
Peter B. Berger, MD, FACC¶,*
* Department of Cardiology, St. Vincents Hospital, Darlinghurst, Australia
Department of Cardiology, Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin, USA
Department of Cardiology, Mayday University Hospital, Surrey, England United Kingdom
Department of Biostatistics, Mayo Clinic, Rochester, Minnesota, USA
|| Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota, USA
¶ Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA

View larger version (35K):
[in a new window]
|
Figure 1 Adverse events within two months of coronary stent placement. MI = myocardial infarction; TVR = target vessel revascularization.
|
|
|